Lv1
30 积分 2024-05-17 加入
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
1小时前
待确认
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis
5小时前
已完结
Cognitive functioning in children with Prader–Willi syndrome during 8 years of growth hormone treatment
4个月前
已完结
Anatomically distinct fibroblast subsets determine skin autoimmune patterns
4个月前
已完结
RNAi-based drug design: considerations and future directions
4个月前
已完结
Colorectal cancer
5个月前
已完结
IgA nephropathy
5个月前
已完结
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
6个月前
已完结
皖公网安备34019202002308
